Fosun High-Tech adjusts pledged equity in Fosun Pharma

As of November 6, 2025, Fosun High-Tech held 961,424,455 shares of Fosun Pharma, representing 36.00% of the company's total share capital. Following a recent pledge and release of pledge, Fosun High-Tech's remaining pledged shares total 546,925,000 A-shares, which accounts for 20.48% of Fosun Pharma's total share capital. The recent transactions included a new pledge of 20,000,000 A-shares for debt repayment and the release of 85,750,000 A-shares.

Including shares held by its concerted parties, Fosun High-Tech's total holdings amounted to 967,812,180 shares, representing 36.24% of the company. Post-transactions, the pledged portion of these combined holdings stands at 56.51%.

Fosun High-Tech confirmed that its production and operations are normal, with sufficient repayment capacity, using sources such as bond issuance, dividends, and investment returns. The company anticipates that 3.431 bn of its pledged shares, representing 37.89% of its holdings, will mature within the next year, with 1.715 bn expected to mature within six months. The pledge adjustments are not expected to adversely affect the company's operations or governance.